Vanguard Group Inc. Acquires 423,184 Shares of Oscar Health, Inc. $OSCR

Vanguard Group Inc. boosted its stake in shares of Oscar Health, Inc. (NYSE:OSCR) by 2.1% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 20,160,399 shares of the company’s stock after acquiring an additional 423,184 shares during the quarter. Vanguard Group Inc. owned approximately 7.80% of Oscar Health worth $381,636,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of OSCR. Straightline Group LLC lifted its position in shares of Oscar Health by 3.7% during the second quarter. Straightline Group LLC now owns 18,082 shares of the company’s stock worth $388,000 after purchasing an additional 640 shares in the last quarter. Wealthspire Advisors LLC raised its position in Oscar Health by 6.7% in the 2nd quarter. Wealthspire Advisors LLC now owns 11,117 shares of the company’s stock worth $238,000 after purchasing an additional 700 shares during the last quarter. PNC Financial Services Group Inc. lifted its holdings in Oscar Health by 14.4% during the 2nd quarter. PNC Financial Services Group Inc. now owns 7,140 shares of the company’s stock worth $153,000 after buying an additional 900 shares in the last quarter. Focus Partners Wealth lifted its holdings in Oscar Health by 1.8% during the 1st quarter. Focus Partners Wealth now owns 55,158 shares of the company’s stock worth $723,000 after buying an additional 949 shares in the last quarter. Finally, Nisa Investment Advisors LLC boosted its position in Oscar Health by 71.4% in the 2nd quarter. Nisa Investment Advisors LLC now owns 2,658 shares of the company’s stock valued at $57,000 after buying an additional 1,107 shares during the last quarter. 75.70% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

OSCR has been the subject of a number of recent research reports. Barclays set a $18.00 target price on Oscar Health and gave the stock an “equal weight” rating in a research report on Monday, January 5th. Piper Sandler upgraded Oscar Health from a “neutral” rating to an “overweight” rating and lifted their price objective for the stock from $13.00 to $25.00 in a research report on Tuesday, November 25th. Stephens began coverage on Oscar Health in a report on Thursday, December 11th. They set an “equal weight” rating and a $17.00 price objective for the company. UBS Group restated a “neutral” rating and set a $15.00 target price on shares of Oscar Health in a research report on Wednesday, February 11th. Finally, Wells Fargo & Company lowered their price target on shares of Oscar Health from $14.00 to $11.00 and set an “underweight” rating for the company in a research report on Thursday, November 13th. Two analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, Oscar Health presently has a consensus rating of “Hold” and an average price target of $16.88.

Oscar Health Trading Up 5.6%

NYSE OSCR opened at $13.67 on Friday. The company has a current ratio of 0.96, a quick ratio of 0.96 and a debt-to-equity ratio of 0.44. Oscar Health, Inc. has a 12 month low of $11.20 and a 12 month high of $23.80. The company has a market capitalization of $4.07 billion, a PE ratio of -7.86 and a beta of 1.90. The stock has a 50-day simple moving average of $14.74 and a 200 day simple moving average of $16.63.

Oscar Health (NYSE:OSCR) last posted its earnings results on Tuesday, February 10th. The company reported ($1.24) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.92) by ($0.32). The company had revenue of $2.76 billion for the quarter, compared to analyst estimates of $3.12 billion. Oscar Health had a negative return on equity of 39.35% and a negative net margin of 3.79%.Oscar Health’s quarterly revenue was up 17.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted ($0.62) earnings per share. Research analysts forecast that Oscar Health, Inc. will post 0.69 EPS for the current year.

Insider Activity

In other news, insider Janet Liang sold 7,338 shares of Oscar Health stock in a transaction on Tuesday, December 2nd. The shares were sold at an average price of $16.59, for a total transaction of $121,737.42. Following the transaction, the insider directly owned 172,527 shares of the company’s stock, valued at $2,862,222.93. This trade represents a 4.08% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Richard Scott Blackley sold 25,135 shares of the company’s stock in a transaction on Tuesday, December 2nd. The shares were sold at an average price of $16.59, for a total transaction of $416,989.65. Following the completion of the sale, the chief financial officer owned 1,351,034 shares of the company’s stock, valued at approximately $22,413,654.06. This represents a 1.83% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 197,125 shares of company stock valued at $3,265,300. 24.39% of the stock is currently owned by company insiders.

Oscar Health Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.